CSPC Pharmaceutical Group (HK:1093) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
CSPC Pharmaceutical Group has renewed lease agreements with CHL and NCP for three years starting January 2025, involving industrial premises in Shijiazhuang, China for drug production. These agreements are categorized as connected transactions under Hong Kong’s Listing Rules, requiring reporting and announcement but exempt from independent shareholder approval. The move indicates CSPC’s strategic alignment with its substantial shareholder’s associates to continue its production activities.
For further insights into HK:1093 stock, check out TipRanks’ Stock Analysis page.
